← Leaderboards
Ann Marie Stowe
Ut Southwestern Medical Center
$5,202,846
Attributed
$7,964,512
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,964,512 · 5
By mechanism
RF1$3,880,320 · 2
R01$2,818,804 · 1
R56$714,524 · 1
R43$550,864 · 1
Top collaborators
- Dwight C. German3 shared
- Rong Zhang3 shared
- David C Zhu3 shared
- Victor V Uteshev-Gaard1 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ying Xian$6,460,808
- Andrew Farley Tyler$53,403
- Dwight C. German$4,063,025
- David C Zhu$6,236,143
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNeuronsImmuneMediatingBrainMaleInfarctionAcutePost StrokeNeuroprotectionStrokeRecoveryStroke RecoveryAlzheimer&AposLeukocytesIschemiaNeuronal PlasticityMigrationExcitotoxicityMotorInterleukin-10In VitroFda ApprovedIn Vitro Testing
Grant awards (16)
B Cells Directly Alter Adaptive Plasticity to Support Functional Recovery After Stroke$389,705
R01 · FY2025 · NS · contact PI
Novel Product Formulation toModulate Alpha7 Nicotinic Receptors for Therapy in Stroke Recovery$550,864
R43 · FY2024 · NS
B Cells Directly Alter Adaptive Plasticity to Support Functional Recovery After Stroke$389,616
R01 · FY2024 · NS · contact PI
Diversity Supplement for Jenny Lutshumba$302,626
RF1 · FY2024 · AG · contact PI
Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" Trial$2,297,829
RF1 · FY2023 · AG · contact PI
Diversity Supplement: B Cells Directly Alter Adaptive Plasticity to Support Functional Recovery After Stroke$103,586
RF1 · FY2023 · NS · contact PI
B Cells Directly Alter Adaptive Plasticity to Support Functional Recovery After Stroke$1,176,279
RF1 · FY2021 · NS · contact PI
Biomarkers to track effective interventions that delay dementia onset in participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" trial$714,524
R56 · FY2021 · AG · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$334,688
R01 · FY2019 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$305,385
R01 · FY2018 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$117,371
R01 · FY2018 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$430,718
R01 · FY2017 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$92,936
R01 · FY2017 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$353,737
R01 · FY2016 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$51,367
R01 · FY2016 · NS · contact PI
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke$353,281
R01 · FY2015 · NS · contact PI